Abstract:Cyclodextrin glycosyltransferase (CGTase; EC 2.4.1.19) is an extracellular enzyme which converts starch into nonreducing, cyclic malto-oligosaccharides called cyclodextrins (CDs). It is a hydrolytic enzyme that carries out reversible intermolecular as well as intramolecular transglycosylation reaction toward cyclization, coupling, and disproportionation of malto-oligosaccharides. CD is a nonreducing closed-ring malto-oligosaccharide with glucose monomers linked with each other by α1 →4 glycosidic bonds. The most common form of CDs are consist with Six, seven, and eight glucose residues, i.e., α-, β-, γ-cyclodextrin, respectively. CGTase exhibits an axis of cyclization either with phenylalanine (Phe) or tyrosine (Tyr), essentially for the formation of CDs. The CGTase enzyme is efficient of transglycosylation and is specifically dependent on the centrally located Tyr residue for cyclization. Similarly, Phe and Arginine (Arg) are known for CD binding residues, whereas, lysine (Lys), and asparagine (Asp) are known for linear substrate binding residues of CGTase enzyme. The kinetics of coupling reaction exhibit the binding of both the donor (CD) and acceptor (monosaccharide) to the active binding cleft of the CGTase enzyme module before processing of CDs. Environmental 126conditions are regulatory aspects for growth of the microbial population and metabolic production. Enhanced CD production could be achieved through providing appropriate conditions. Induction of more thermostable CGTase enzymes are required to increase the CD production by ignoring the traditional problem of increase in temperature with inactivating the enzyme. Fermentation conditions such as the concentration of nutrients, temperature, and compositions of the carbon and nitrogen sources determine the optimum production of CGTase. Similarly, the CD-drug inclusion complex can be utilized for management of drug toxicity and regulated drug delivery. Cyclodextrin glycosyltransferase (CGTase) is an extracellular enzyme which converts starch into nonreducing, cyclic malto-oligosaccharides called cyclodextrins (CDs). In modern days, CDs perform as a recognized guest molecule in the area of molecular complexation. CDs are primarily cyclic, cage-like glucose residues produced from enzymatic hydrolysis of starch with help of the enzyme CGTase. An appropriate guest molecule substitutes the water from the CD cavity, leading to the formation of the CD-inclusion complex. The solubility of inclusion complex and CDs are inversely proportional to each other. Inclusion complex with guest molecule of low water solubility usually results with decrease in solubility of CD, where solubility of inclusion complex is generally less than that of the CD, and greater than the guest molecule. Encapsulation of drug molecules within CD as guest molecules has become an area of new interest for efficient drug delivery function.

Surface engineering of cyclodextrin glycosyltransferase reveals structural compactness and rigidity responsible for enhanced organic solvents resistance

Engineering of Cyclodextrin Glycosyltransferase through a Size/Polarity Guided Triple-Code Strategy with Enhanced alpha-Glycosyl Hesperidin Synthesis Ability

Engineering of cyclodextrin glycosyltransferase from Paenibacillus macerans for enhanced product specificity of long-chain glycosylated sophoricosides

Engineering of Cyclodextrin Glycosyltransferase Reveals pH-Regulated Mechanism of Enhanced Long-Chain Glycosylated Sophoricoside Specificity

Kinetics guided engineering of cyclodextrin glycosyltransferase with enhanced intermolecular transglycosylation activity

Thermostable Cyclodextrin Glycosyltransferase (CGTase): Recent Advances in Pharmaceutical Application of Cyclodextrins and Its Enzymatic Production

Improved production of cyclodextrin glycosyltransferase from Bacillus stearothermophilus NO2 in Escherichia coli via directed evolution

Developmental Science and Preventive Interventions for Children at Environmental Risk

High-level production of γ-cyclodextrin glycosyltransferase in recombinant Escherichia coli BL21 (DE3): culture medium optimization, enzymatic properties characterization, and product specificity analysis

Rational Design of Cyclodextrin Glycosyltransferase with Improved Hesperidin Glycosylation Activity

Variants at Position 603 of the CGTase from Bacillus Circulans STB01 for Reducing Product Inhibition.

[Breeding, Optimized Fermentation and Enzymatic Properties of a Bacillus Licheniformis Mutant Producing Cyclomaltodextrin Glucanotransferase].

Sulfasalazine-induced linear immunoglobulin A bullous dermatosis with DRESS.

A review on recent upgradation and strategies to enhance cyclodextrin glucanotransferase properties for its applications

Systemic sarcoidosis associated with interferon-alpha treatment for chronic myelogenous leukemia.

Domain shuffling of cyclodextrin glucanotransferases for tailored product specificity and thermal stability

Going beyond Prozac.

Engineering of Cyclodextrin Glycosyltransferase through a Size/Polarity Guided Triple-Code Strategy with Enhanced α-Glycosyl Hesperidin Synthesis Ability

Maltose binding site 2 mutations affect product inhibition of Bacillus circulans STB01 cyclodextrin glycosyltransferase

Effect of osmolytes on the interaction of flavin adenine dinucleotide with muscle glycogen phosphorylase b.

Cyclodextrin glycosyltransferase production by free cells of Bacillus circulans DF 9R in batch fermentation and by immobilized cells in a semi-continuous process